The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector
Written By
Partner
Ireland
I am an experienced Irish lawyer. I specialise in complex technology, data and IP transactions, and advise innovative clients on the laws and regulations applicable to related products and services offered in Ireland and other parts of the European Union.
Associate
Ireland
I am an associate in Bird & Bird's International Commercial Group, based in the Dublin office where I specialise in Technology, Media, Entertainment and Sports.
Related
Practices
Sectors
Trending Topics
Regions
Countries
Offices
The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased focus on the risks for medical device manufacturers and healthcare providers inherent in the data they collect and hold, including the risks posed by the ongoing threat of cyber-attacks. This is where the NIS2 Directive and the CER Directive come in.
In this article we will consider the Network and Information Systems Directive (EU) 2022/0383 (“NIS2”) and the Directive on the Resilience of Critical Entities (EU) 2022/2557 (“CER Directive”) and the impact that they will have on medical device manufacturers and healthcare providers.
